1-3 of 3
Pierre-Jean Saulnier, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Value of Resting Heart Rate on Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients: A competing risk analysis in a prospective cohort

Aurelie Miot, MD, Stéphanie Ragot, PHARMAD, Wala Hammi, MSC, Pierre-Jean Saulnier, MD, Philippe Sosner, MD, Xavier Piguel, MD, Florence Torremocha, MD, Richard Marechaud, MD, Samy Hadjadj, MD
Journal: Diabetes Care
Diabetes Care 2012;35(10):2069–2075
https://doi.org/10.2337/dc11-2468
Published: 11 September 2012
View article titled, Prognostic Value of Resting Heart Rate on Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients: <subtitle>A competing risk analysis in a prospective cohort</subtitle>
Open the PDF for Prognostic Value of Resting Heart Rate on Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients: <subtitle>A competing risk analysis in a prospective cohort</subtitle> in another window
Includes: Supplementary data
Journal Articles

Impact of Natriuretic Peptide Clearance Receptor (NPR3) Gene Variants on Blood Pressure in Type 2 Diabetes

Pierre-Jean Saulnier, MD, Ronan Roussel, MD, Jean Michel Halimi, MD, Jeremie Lebrec, PHD, Dured Dardari, MD, Sulyia Maimaitiming, PHD, Gérard Guilloteau, MD, Xavier Prugnard, PHARMD, Richard Marechaud, MD, Stephanie Ragot, PHARMD, Michel Marre, MD, Samy Hadjadj, MD, for the SURDIAGENE, DIAB2NEPHROGENE, and DIABHYCAR study groups
Journal: Diabetes Care
Diabetes Care 2011;34(5):1199–1204
https://doi.org/10.2337/dc10-2057
Published: 20 April 2011
View article titled, Impact of Natriuretic Peptide Clearance Receptor (<em>NPR3</em>) Gene Variants on Blood Pressure in Type 2 Diabetes
Open the PDF for Impact of Natriuretic Peptide Clearance Receptor (<em>NPR3</em>) Gene Variants on Blood Pressure in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Prognostic Value of the Insertion/Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects: Results from the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies

Samy Hadjadj, MD, PHD, Frédéric Fumeron, PHD, Ronan Roussel, MD, PHD, Pierre-Jean Saulnier, MD, Yves Gallois, PHARMD, PHD, Amos Ankotche, MD, Florence Travert, MD, Charbel Abi Khalil, MD, Aurélie Miot, MSC, François Alhenc-Gelas, MD, PHD, Michel Lievre, MD, PHD, Michel Marre, MD, PHD, on behalf of the DIABHYCAR, DIAB2NEPHROGENE, and SURDIAGENE study groups
Journal: Diabetes Care
Diabetes Care 2008;31(9):1847–1852
https://doi.org/10.2337/dc07-2079
Published: 01 September 2008
View article titled, Prognostic Value of the Insertion/Deletion Polymorphism of the <em>ACE</em> Gene in Type 2 Diabetic Subjects: <subtitle>Results from the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies</subtitle>
Open the PDF for Prognostic Value of the Insertion/Deletion Polymorphism of the <em>ACE</em> Gene in Type 2 Diabetic Subjects: <subtitle>Results from the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies</subtitle> in another window
Includes: Supplementary data